HSBC/CALL/CENTENE/75/0.1/15.01.25 Share Price

Warrant

DE000HG8KC03

Real-time BOERSE MUENCHEN 07:06:30 27/06/2024 pm IST
0.34 EUR 0.00% Intraday chart for HSBC/CALL/CENTENE/75/0.1/15.01.25
Current month-34.62%
1 month-52.78%
Date Price Change
27/24/27 0.34 0.00%
26/24/26 0.34 -5.56%
25/24/25 0.36 0.00%
24/24/24 0.36 0.00%
21/24/21 0.36 +5.88%

Real-time BOERSE MUENCHEN

Last update June 27, 2024 at 07:06 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer HSBC
WKN HG8KC0
ISINDE000HG8KC03
Date issued 28/02/2023
Strike 75 $
Maturity 15/01/2025 (202 Days)
Parity 10 : 1
Emission price 1.36
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.3
Lowest since issue 0.33
Delta0.4x
Omega 7.343
Premium17x
Gearing18.44x
Moneyness 0.8963
Difference Strike 7.72 $
Difference Strike %+10.29%
Spread 0.04
Spread %11.11%
Theoretical value 0.3300
Implied Volatility 28.47 %
Total Loss Probability 68.43 %
Intrinsic value 0.000000
Present value 0.3300
Break even 78.54 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
67.72 USD
Average target price
87.52 USD
Spread / Average Target
+29.23%
Consensus